SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending as traders discuss its low float and potential for a short squeeze, drawing comparisons to stocks like SMX. Community members are highlighting key price levels as potential triggers for further upward momentum. Speculation is fueled by social media buzz around a prior AI server deal and the company's structure after a reverse split.

Amplify ETF Trust - Amplify Seymour Cannabis ETF

Amplify Seymour Cannabis ETF

$CNBS is trending due to renewed sector-wide optimism fueled by reports that the Trump administration may reclassify marijuana, potentially leading to significant tax relief and easier access to banking services for cannabis companies. The community is closely watching for details on the executive order, with some expressing skepticism while others highlight Tim Seymour's connection to the ETF. Overall, the ETF's volatility and potential for rapid price swings are key discussion points.

Tennant Co. engages in the design, manufacture, and marketing of cleaning solutions. Its products include equipment for maintaining surfaces in industrial, commercial, and outdoor environments, detergent-free and other sustainable cleaning technologies, cleaning tools and supplies, and coatings for protecting, repairing and upgrading surfaces. It operates through the following geographic segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by George Henry Tennant in 1870 and is headquartered in Eden Prairie, MN.

Tennant Co.

Tennant Co. is trending as investors are evaluating a potential acquisition of Nilfisk amidst a competitive bidding environment, with some believing a merger would create synergies. Community members are also assessing the company's strategic direction, particularly regarding expansion in smaller space cleaning and the potential impact of robotics and AI. Overall sentiment is mixed, with some viewing $TNC as undervalued, while others are wary of insider selling.

Stafi is the first DeFi protocol unlocking liquidity of staked assets. Users can stake PoS tokens through Stafi and receive rTokens in return, which are available for trading while still earning staking rewards. FIS is the native token on Stafi Chain. FIS is required to provide security to the network by staking, pay for transaction fees on the Stafi chain, mint & redeem rTokens.

StaFi

StaFi's FIS token is trending amid discussions around its potential for a major price shift, particularly in relation to a descending wedge pattern and key price levels; however, a recent Binance delisting announcement has introduced concerns about volatility and potential downsides. The community is weighing the delisting news against StaFi's ongoing efforts to expand its multi-chain liquid staking infrastructure and develop AI-powered systems, creating a mixed sentiment.

The Root Network

The Root Network ($ROOT) is trending as the community discusses its potential within the metaverse and its connection to Futureverse. Conversations revolve around recent price movements, accumulation strategies, and speculation about a potential breakout similar to other metaverse projects. Some users are also highlighting partnerships and the project's ecosystem, while others are inquiring about price discrepancies across exchanges.

Berachain

Berachain ($BERA) is trending as traders discuss its Proof-of-Liquidity model and potential for future growth, while others express concerns about its performance since launch. Community members are actively debating entry points and discussing potential price targets. The recent Bectra upgrade and integrations with platforms like PAW Chain are also sparking interest.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

$401JK is trending as community members rally around the idea of a decentralized retirement fund, challenging traditional 401(k) plans. Discussions highlight upcoming staking and the project's evolution from a meme to a potential financial movement. Despite some price volatility, the community expresses strong conviction and a belief in the project's long-term vision.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin ($XCN) is experiencing increased community chatter driven by its recent listing on Robinhood, with users speculating on increased exposure and easier access for U.S. retail investors. Bullish sentiment is further fueled by upcoming Goliath Mainnet, with some seeing the Robinhood listing as a signal of legitimacy and visibility. Community members are also sharing price predictions and discussing staking percentages.

Marriott International, Inc. engages in the operation and franchise of hotel, residential, and timeshare properties. It operates through the following geography segments: United States and Canada, Europe, Middle East, and Africa, Asia Pacific, and Greater China. Its brands include Marriott Bonvoy, The Ritz-Carlton, Edition, W Hotels Worldwide, The Luxury Collection, and Stregis Hotels and Resorts etc. The company was founded by John Willard Marriott and Alice Sheets Marriott in 1927 and is headquartered in Bethesda, MD.

Marriott International, Inc. - Ordinary Shares - Class A

Marriott International Inc

Marriott International is trending as investors analyze its growth strategy and financial outlook following its recent earnings report. The community is focused on both revenue per available room (RevPAR) and the potential impact of broader economic trends on the travel sector. Recent data breaches and executive moves are also contributing to the discussion around the stock.

Wealthfront Corp.engages in the provision of automated digital investment advisory services. The company was founded by Andrew Samuel Rachleff and Daniel Joseph Carroll in January 2007 and is headquartered in Palo Alto, CA.

Wealthfront Corp.

Wealthfront ($WLTH) is trending following its IPO, with the community discussing its potential as a long-term play in the robo-advisor space and comparing it to competitors. Some are optimistic due to strong anchor support and the company's focus on millennial and Gen Z clients, while others are awaiting chart data and analyzing its initial trading behavior. The IPO was reportedly oversubscribed, and there's chatter about potential weekend advertising and significant upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dogwood Therapeutics, Inc. (DWTX) shares surged 50% in the pre-market session on Monday after the company announced that it has secured a license to develop Serpin Pharma’s intravenous formulation of SP16 to manage cancer-related pain (CRP).The royalty-free, global license will enable the company to develop SP16 for a broad range of chemotherapy-induced neuropathy symptoms as well.In return, Sepin Pharma and its designated affiliates will get 7.31% of the company’s common stock, on a fully diluted basis. This includes 382,034 shares of DWTX common stock and 179.1878 shares of a new series of non-voting convertible preferred stock, it said.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/DWTX">DWTX stock</a> stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels.Dogwood <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/09/29/3157595/0/en/Dogwood-Therapeutics-Secures-Exclusive-Worldwide-Royalty-Free-License-to-Develop-and-Commercialize-SP16-as-a-Treatment-for-Cancer-Related-Pain-in-an-All-Stock-Transaction-Underscor.html">said</a> that SP16 has demonstrated both anti-inflammatory and neural repair activity. An early-stage trial of the intravenous formulation of SP16, fully funded by the National Cancer Institute, is slated to start patient enrollment in the first half of 2026.“The National Cancer Institute’s funding of the SP16 IV Phase 1b program obviates the need to use our existing capital in the near-term to advance SP16 into clinical development,” CEO Greg Duncan said.The company also noted that SP16 could complement its lead candidate Halneuron, which has demonstrated statistically significant and clinically meaningful pain reductions in general cancer pain, as well as chemotherapy-induced neuropathic pain, respectively.DWTX stock has more than tripled this year and risen by about 79% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pharma-lobby-announces-new-website-to-connect-patients-with-manufacturer-direct-patient-programs/chDuciYR3JJ">Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Programs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Dogwood Therapeutics Stock Soars Pre-Market On Securing License For Cancer-Related Pain Management Drug 

In return for the license, Sepin Pharma and its designated affiliates will get 7.31% of Dogwood’s common stock, on a fully diluted basis.

Equity

In return for the license, Sepin Pharma and its designated affiliates will get 7.31% of Dogwood’s common stock, on a fully diluted basis.


Shares of Dogwood Therapeutics Inc. rose over 18% in premarket trading Friday, following a jaw-dropping 370% surge in the previous session.&nbsp;Trading volume was over 62 times the daily average, with retail investors on Stocktwits making it the most discussed biotech stock before the bell.While there was no fresh news on Friday, the rally appears to stem from an&nbsp;earlier announcement.&nbsp;Dogwood disclosed on Tuesday that it plans to begin dosing the first patient in its Phase 2b HALT-CINP trial in the first quarter of 2025.&nbsp;The trial evaluates Halneuron, a non-opioid therapy aimed at alleviating neuropathic pain linked to chemotherapy.The company’s focus on pain and fatigue-related disorders has generated excitement, bolstered by its non-opioid analgesic and antiviral platforms.&nbsp;Retail attention on Stocktwits has skyrocketed. The stock saw an 8,500% jump in message volume on Thursday, with&nbsp;its retail&nbsp;following increasing by 18% in a single day.&nbsp;<stembedurl>https://stocktwits.com/OFFC18/message/601301523</stembedurl><stembedurl>https://stocktwits.com/BullsEye2000/message/601306713</stembedurl>Dogwood stock is up over 400% year-to-date and has lost 95% over the past 12 months.&nbsp;The massive surge has reignited attention, although its low liquidity and early-stage pipeline make it a volatile bet.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

Dogwood Therapeutics Becomes Most Actively Discussed Biotech Stock Among Retail Traders After Stunning 370% Surge

The company’s focus on pain and fatigue-related disorders has generated excitement, bolstered by its non-opioid analgesic and antiviral platforms.

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

DWTX
Dogwood Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DWTX News

DWTXDogwood Therapeutics Inc.